Membrane transporters in drug development
Open accessThe DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Abstract
Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, the human genome has been proven to have more than 400 membrane transporters, which are divided into two families: ATP binding cassette (ABC) and solute carrier (SLC) transporters [114].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-citationMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Cited by
Items 401–500 of 1,008
Targeting SLC transporters: small molecules as modulators and therapeutic opportunities
Schlessinger, A., Zatorski, N., Hutchinson, K., & Colas, C. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.05.011 · Cited by 94
Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III
Bednarczyk, D., & Boiselle, C. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1085111 · Cited by 88
Lebedeva, I. V., Pande, P., & Patton, W. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022429 · Cited by 88
Proton movement and coupling in the POT family of peptide transporters
Parker, J. L., Li, C., Brinth, A., Wang, Z., Vogeley, L., Solcan, N., Ledderboge-Vucinic, G., Swanson, J. M. J., Caffrey, M., Voth, G. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710727114 · Cited by 89
Drug Targeting Strategies Based on Charge Dependent Uptake of Nanoparticles into Cancer Cells
Saadat, M., Zahednezhad, F., Zakeri-Milani, P., Reza Heidari, H., Shahbazi-Mojarrad, J., & Valizadeh, H. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30318 · Cited by 88
“P-gp is over-expressed in the malignant tissues of almost 40-50% of mammary neoplasm patients; so that is a promising target which should be considered in nano-system designation (159, 160).”
BackgroundMolecular Modeling and Ligand Docking for Solute Carrier (SLC) Transporters
Schlessinger, A., Khuri, N., Giacomini, K. M., & Šali, A. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313070007 · Cited by 94
Self-citationShitara, Y., Takeuchi, K., Nagamatsu, Y., Wada, S., Sugiyama, Y., & Horie, T. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-096 · Cited by 87
Self-citationMultilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
Achilli, T.-M., McCalla, S., Meyer, J., Tripathi, A., & Morgan, J. R. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500002y · Cited by 91
Pharmacogenomics of adverse drug reactions: implementing personalized medicine
Wei, C.-Y., Michael Lee, M.-T., & Chen, Y.-T. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds341 · Cited by 87
Skerratt, S. E., Andrews, M., Bagal, S. K., Bilsland, J., Brown, D., Bungay, P. J., Cole, S., Gibson, K. R., Jones, R., Morao, I., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00850 · Cited by 81
Clinical pharmacokinetics and pharmacodynamics of lenalidomide
Chen, N., Zhou, S., & Palmisano, M. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0432-1 · Cited by 86
Peng, Y., Cheng, Z., & Xie, F. (2021) · Metabolites · doi:10.3390/metabo11020075 · Cited by 95
Honer, M., Gobbi, L. B., Martarello, L., & Comley, R. A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.012 · Cited by 86
Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism
Joyce, H., McCann, A., CLYNES, M. M., & Larkin, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1028356 · Cited by 89
In situ perfusion in rodents to explore intestinal drug absorption: Challenges and opportunities
Stappaerts, J., Brouwers, J., Annaert, P., & Augustijns, P. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.035 · Cited by 91
Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3
Bruyn, T. D., Fattah, S., Stieger, B., Augustijns, P., & Annaert, P. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22694 · Cited by 86
Role of prostacyclin in pulmonary hypertension
Mitchell, J. A., Ahmetaj‐Shala, B., Kirkby, N. S., Wright, W. R., Mackenzie, L. S., Reed, D. M., & Mohamed, N. A. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.53 · Cited by 91
Functional profiles of orphan membrane transporters in the life cycle of the malaria parasite
Kenthirapalan, S., Waters, A. P., Matuschewski, K., & Kooij, T. W. A. (2016) · Nature Communications · doi:10.1038/ncomms10519 · Cited by 91
Bi, Y., Costales, C., Mathialagan, S., West, M. A., Eatemadpour, S., Lazzaro, S., Tylaska, L. A., Scialis, R. J., Zhang, H., Umland, J. P., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257600 · Cited by 87
Microphysiological Systems: Design, Fabrication, and Applications
Wang, K., Man, K., Liu, J., Liu, Y., Chen, Q., Zhou, Y., & Yang, Y. S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01667 · Cited by 90
Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2
Kowal, J., Ni, D., Jackson, S. M., Manolaridis, I., Stahlberg, H., & Locher, K. P. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166980 · Cited by 84
Drug Disposition in Pathophysiological Conditions
Gandhi, A. S., Moorthy, B., & Ghose, R. (2012) · Current Drug Metabolism · doi:10.2174/138920012803341302 · Cited by 90
Cheng, Y., Vapurcuyan, A., Shahidullah, M., Aleksunes, L. M., & Pelis, R. M. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042036 · Cited by 85
The Proteome of Filter-Grown Caco-2 Cells With a Focus on Proteins Involved in Drug Disposition
Ölander, M., Wiśniewski, J. R., Matsson, P., Lundquist, P., & Artursson, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.030 · Cited by 91
The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs
Stojančević, M., Bojić, G., Salami, H. A., & Momir, M. (2014) · Current Issues in Molecular Biology · doi:10.21775/cimb.016.055 · Cited by 97
Azzi, P. B.-E., Sharanek, A., Burban, A., Li, R., Guével, R. L., Abdel‐Razzak, Z., Stieger, B., Guguen‐Guillouzo, C., & Guillouzo, A. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv041 · Cited by 88
Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination
Zhang, J., Wang, H., Fan, Y., Yu, Z., & You, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107647 · Cited by 84
Bi, Y., Qiu, X., Rotter, C. J., Kimoto, E., Piotrowski, M. A., Varma, M. V. S., El‐Kattan, A. F., & Lai, Y. (2013) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1861 · Cited by 91
The Mechanism of Enterohepatic Circulation in the Formation of Gallstone Disease
Cai, J.-S., & Chen, J.-H. (2014) · The Journal of Membrane Biology · doi:10.1007/s00232-014-9715-3 · Cited by 82
Shen, H., Yang, Z., Mintier, G. A., Han, Y., Chen, C., Balimane, P. V., Jemal, M., Zhao, W., Zhang, R., Kallipatti, S., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.200691 · Cited by 84
Bisi, A., Cappadone, C., Rampa, A., Farruggia, G., Sargenti, A., Belluti, F., Martino, R. M. C. D., Malucelli, E., Meluzzi, A., Iotti, S., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.01.020 · Cited by 84
The Fraction Dose Absorbed, in Humans, and High Jejunal Human Permeability Relationship
Dahan, A., Lennernäs, H., & Amidon, G. L. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300140h · Cited by 83
Volpe, D. A., Hamed, S. S., & Zhang, L. K. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9554-7 · Cited by 103
Self-citationNon-Systemic Drugs: A Critical Review
Charmot, D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504858 · Cited by 80
Potential Role of Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport
Ingelman‐Sundberg, M., Zhong, X., Hankinson, O., Beedanagari, S., Yu, A., Peng, L., & Osawa, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053157 · Cited by 83
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Keemink, J., Mårtensson, E., & Bergström, C. A. S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00811 · Cited by 82
Highlights from the International Transporter Consortium Second Workshop
Zamek-Gliszczynski, M. J., Hoffmaster, K. A., Tweedie, D. J., Giacomini, K. M., & Hillgren, K. M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.126 · Cited by 82
Self-citationDunvald, A. D., Järvinen, E., Mortensen, C., & Stage, T. B. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2432 · Cited by 82
Nieto-Montesinos, R., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.034 · Cited by 90
Lacy, S. A., Hsu, B. H., Miles, D., Aftab, D. T., Wang, R., & Nguyen, L. T. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063610 · Cited by 87
Stopfer, P., Gießmann, T., Hohl, K., Sharma, A. K., Ishiguro, N., Taub, M. E., Zimdahl‐Gelling, H., Ganßer, D., Wein, M., Ebner, T., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.406 · Cited by 85
Intracellular drug bioavailability: a new predictor of system dependent drug disposition
Mateus, A., Treyer, A., Wegler, C., Karlgren, M., Matsson, P., & Artursson, P. (2017) · Scientific Reports · doi:10.1038/srep43047 · Cited by 91
Miyauchi, E., Tachikawa, M., Declèves, X., Uchida, Y., Bouillot, J., Poitou, C., Oppert, J., Mouly, S. J., Bergmann, J., Terasaki, T., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00085 · Cited by 82
The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion
Khunweeraphong, N., Stockner, T., & Kuchler, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-11794-w · Cited by 87
Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors
Poongavanam, V., Haider, N., & Ecker, G. F. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.045 · Cited by 79
Fardel, O., Kolasa, É., & Vée, M. L. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.637918 · Cited by 87
Evaluation of transporters in drug development: Current status and contemporary issues
Lee, S., Arya, V., Yang, X., Volpe, D. A., & Zhang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.020 · Cited by 83
Self-citationMultispecific Drug Transporter Slc22a8 (Oat3) Regulates Multiple Metabolic and Signaling Pathways
Wu, W., Jamshidi, N., Eraly, S. A., Liu, H. C., Bush, K. T., Palsson, B. Ø., & Nigám, S. K. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052647 · Cited by 82
Scaffold‐Free Liver‐On‐A‐Chip with Multiscale Organotypic Cultures
Weng, Y., Chang, S., Shih, M., Tseng, S., & Lai, C. (2017) · Advanced Materials · doi:10.1002/adma.201701545 · Cited by 79
Small molecule splicing modifiers with systemic HTT-lowering activity
Bhattacharyya, A., Trotta, C. R., Narasimhan, J., Wiedinger, K., Li, W., Effenberger, K. A., Woll, M. G., Jani, M., Risher, N., Yeh, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27157-z · Cited by 85
Scheer, N., & Wilson, I. D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.002 · Cited by 76
Drug uptake transporters in antiretroviral therapy
Minuesa, G., Huber‐Ruano, I., Pastor‐Anglada, M., Koepsell, H., Clotet, B., & Martínez‐Picado, J. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.007 · Cited by 79
Dutheil, F., Jacob, A., Dauchy, S., Beaune, P. H., Scherrmann, J., Declèves, X., & Loriot, M. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.510832 · Cited by 79
Mease, K. M., Sane, R. S., Podila, L., & Taub, M. E. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23069 · Cited by 84
Diallinas, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00207 · Cited by 87
Yu, A., Tian, Y., Tu, M., Ho, P. Y., & Jilek, J. L. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067470 · Cited by 81
Tsuruya, Y., Kato, K., Sano, Y., Imamura, Y., Maeda, K., Kumagai, Y., Sugiyama, Y., & Kusuhara, H. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071472 · Cited by 80
Self-citationO’Shea, J. P., Augustijns, P., Brandl, M., Brayden, D. J., Brouwers, J., Griffin, B. T., Holm, R., Jacobsen, A.-C., Lennernäs, H., Vinarov, Z., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106098 · Cited by 85
Saiyed, A. N., Vasavada, A. R., & Johar, K. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00413-9 · Cited by 84
Clinical Association Between Pharmacogenomics and Adverse Drug Reactions
Zhou, Z.-W., Chen, X.-W., Sneed, K., Yang, Y.-X., Zhang, X., He, Z.-X., Chow, K., Yang, T., Duan, W., & Zhou, S.-F. (2015) · Drugs · doi:10.1007/s40265-015-0375-0 · Cited by 86
Mazur, C. S., Marchitti, S. A., Dimova, M. P., Kenneke, J. F., Lumen, A., & Fisher, J. W. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs167 · Cited by 78
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective
Maliepaard, M., Nofziger, C., Papaluca, M., Zineh, I., Uyama, Y., Prasad, K., Grimstein, C., Pacanowski, M. A., Ehmann, F., Dossena, S., et al. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3931 · Cited by 87
VARIDT 1.0: variability of drug transporter database
Yin, J., Sun, W. C., Li, F., Hong, J., Li, X., Zhou, Y., Lu, Y., Liu, M., Zhang, X. Z., Chen, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz878 · Cited by 77
Mutsaers, H. A. M., Caetano-Pinto, P., Seegers, A. E. M., Dankers, A. C. A., van den Broek, P. H. H., Wetzels, J. F. M., van den Brand, J. A. J. G., van den Heuvel, L. P., Hoenderop, J. G. J., Wilmer, M. J. G., et al. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.07.020 · Cited by 77
Transporter-Mediated Drug–Drug Interactions
Zhang, L., Sm, H., & Lesko, L. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.359 · Cited by 78
Self-citationWorley, R. R., & Fisher, J. W. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.10.017 · Cited by 81
Apple juice greatly reduces systemic exposure to atenolol
Jeon, H., Jang, I., Lee, S., Ohashi, K., Kotegawa, T., Ieiri, I., Cho, J., Yoon, S. H., Shin, S., Yu, K., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04324.x · Cited by 77
Chang, J. H., Plise, E. G., Cheong, J., Ho, Q., & Lin, M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4001348 · Cited by 77
Intracellular transport of nanocarriers across the intestinal epithelium
Fan, W., Xia, D., Zhu, Q., Hu, L., & Gan, Y. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.007 · Cited by 83
Yoshida, K. J., Zhao, P., Zhang, L., Abernethy, D. R., Rekić, D., Reynolds, K. S., Galetin, A., & Huang, S.-M. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.045 · Cited by 78
Self-citationCamenisch, G., & Umehara, K. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1784 · Cited by 76
Imaging techniques to study drug transporter function in vivo
Tournier, N., Stieger, B., & Langer, O. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.006 · Cited by 79
Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work
Sohlenius-Sternbeck, A.-K., & Terelius, Y. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000552 · Cited by 82
Brouwer, K. L. R., Evers, R., Hayden, E. R., Hu, S., Li, C. Y., zu Schwabedissen, H. E. M., Neuhoff, S., Oswald, S., Piquette‐Miller, M., Saran, C., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2605 · Cited by 78
Self-citationPharmacokinetic drug–drug interactions with methotrexate in oncology
Levêque, D., Santucci, R., Gourieux, B., & Herbrecht, R. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.57 · Cited by 76
Hosey, C. M., Chan, R., & Benet, L. Z. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9845-2 · Cited by 86
Self-citationChu, X., Chan, G. H., & Evers, R. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.007 · Cited by 76
Self-citationRole of ABC Transporters in Fluoropyrimidine-Based Chemotherapy Response
Nies, A. T., Magdy, T., Schwab, M. G., & Zanger, U. M. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.10.007 · Cited by 87
Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy
Cao, L., Zhu, Y., Wang, W., Wang, G., Zhang, S., & Cheng, H. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.798882 · Cited by 82
Selective drug delivery to the retinal cells: Biological barriers and avenues
Ramsay, E., Lajunen, T., Bhattacharya, M., Reinisalo, M., Rilla, K. J., Kidron, H., Terasaki, T., & Urtti, A. O. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.028 · Cited by 83
Ebrahimi, N., Manavi, M. S., Nazari, A., Momayezi, A., Faghihkhorasani, F., Abdulwahid, A. R. R., Rezaei‐Tazangi, F., Kavei, M., Rezaei, R., Mobarak, H., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117263 · Cited by 82
RetractedPharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences
Oga, E. F., Sekine, S., Shitara, Y., & Horie, T. (2015) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-015-0296-z · Cited by 84
Dolton, M. J., Roufogalis, B. D., & McLachlan, A. J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.159 · Cited by 83
ABC Proteins Protect the Human Body and Maintain Optimal Health
Ueda, K. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.100816 · Cited by 87
Ahmadimoghaddam, D., Zemánková, L., Nachtigal, P., Doleželová, E., Neumanova, Z., Červený, L., Čečková, M., Kacerovský, M., Mičuda, S., & Štaud, F. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.105064 · Cited by 78
Active intestinal drug absorption and the solubility-permeability interplay
Porat, D., & Dahan, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.058 · Cited by 78
Barnett, S., Ogungbenro, K., Ménochet, K., Shen, H., Lai, Y., Humphreys, W. G., & Galetin, A. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.983 · Cited by 75
Minimizing Context Dependency of Gene Networks Using Artificial Cells
Ding, Y., Contreras-Llano, L. E., Morris, E. J., Mao, M., & Tan, C. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b10029 · Cited by 75
An updated patent review on P-glycoprotein inhibitors (2011-2018)
Leopoldo, M., Nardulli, P., Contino, M., Leonetti, F., Luurtsema, G., & Colabufo, N. A. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1618273 · Cited by 75
Zoghbi, M. E., Mok, L., Swartz, D. J., Singh, A., Fendley, G. A., Urbatsch, I. L., & Altenberg, G. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.814186 · Cited by 76
Emerging Roles of the Human Solute Carrier 22 Family
Yee, S. W., & Giacomini, K. M. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000702 · Cited by 71
Self-citationDealing with the complex drug–drug interactions: Towards mechanistic models
Varma, M. V. S., Pang, K. S., Isoherranen, N., & Zhao, P. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1934 · Cited by 82
Role of Hepatic Efflux Transporters in Regulating Systemic and Hepatocyte Exposure to Xenobiotics
Pfeifer, N. D., Hardwick, R. N., & Brouwer, K. L. R. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140021 · Cited by 82
Self-citationPurely in Silico BCS Classification: Science Based Quality Standards for the World’s Drugs
Dahan, A., Wolk, O., Kim, Y. H., Ramachandran, C., Crippen, G. M., Takagi, T., Bermejo, M., & Amidon, G. L. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400485k · Cited by 78
Neurobiology of glycine transporters: From molecules to behavior
Marques, B. L., Oliveira‐Lima, O. C., Carvalho, G. A., Chiareli, R. A., Ribeiro, R. I., Parreira, R. C., Freitas, E. M. D. M., Resende, R. R., Klempin, F., Ulrich, H., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.025 · Cited by 77
Pharmacogenetics of Statin-Induced Myotoxicity
Kee, P. S., Chin, P. K. L., Kennedy, M. A., & Maggo, S. D. S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.575678 · Cited by 76
Pharmaceutical Excipients Influence the Function of Human Uptake Transporting Proteins
Engel, A., Oswald, S., Siegmund, W., & Keiser, M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3001815 · Cited by 73
Modern Prodrug Design for Targeted Oral Drug Delivery
Dahan, A., Zimmermann, E. M., & Ben‐Shabat, S. (2014) · Molecules · doi:10.3390/molecules191016489 · Cited by 73
Sørensen, B. H., Thorsteinsdottir, U. A., & Lambert, I. H. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00274.2014 · Cited by 74
Zamek‐Gliszczynski, M. J., Ruterbories, K. J., Ajamie, R. T., Wickremsinhe, E. R., Pothuri, L., Rao, M. V. S., Basavanakatti, V. N., Pinjari, J., Ramanathan, V. K., & Chaudhary, A. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22452 · Cited by 77
Self-citation
Metadata
- Authors
- The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Wah Yee, S., Zamek-Gliszczynski, M. J., & Zhang, L.
- Affiliations
- University of California, San Francisco (US)
- United States Food and Drug Administration (US)
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Abbott (United States) (US)
- Eli Lilly (United States) (US)
- Novartis (United States) (US)
- RIKEN (JP)
- German Cancer Research Center (DE)
- Western University (CA)
- GlaxoSmithKline (United Kingdom) (GB)
- Genentech (US)
- University of Maryland, Baltimore (US)
- University of Arizona (US)
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-03
- Volume
- 9
- Issue
- 3
- Pages
- 215-236
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3326076
- OpenAlex
- W2079197876
- Cited by
- 3,340
- References
- 225
- Citations by year
- 2026: 105 · 2025: 118 · 2024: 153 · 2023: 175 · 2022: 180 · 2021: 237 · 2020: 187 · 2019: 219 · 2018: 234 · 2017: 216 · 2016: 242 · 2015: 233 · 2014: 248 · 2013: 316 · 2012: 254
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- National Institutes of Health (GM61390)
- U.S. Food and Drug Administration
- National Institute of General Medical Sciences (GM61390, R01GM041935, U19GM061390, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080801, R01DK061425)
- National Institute of Environmental Health Sciences (P30ES006694)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- membrane transporters, drug transporters, drug-drug interactions, pharmacokinetics, drug absorption, drug disposition, drug development, drug safety and efficacy, drug labeling
- MeSH terms
- Animals, Computer Simulation, Decision Trees, Drug Interactions, Drug Evaluation, Preclinical, Humans, Drug Approval, Mice, Knockout, Membrane Transport Proteins, Mice, Prescription Drugs, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.